able to continuously generate cash sales in each branch. 3. Analysis of Operating Results Profit & Loss Statements (MB) for the Quarter 1 Ending 31 Mar +/(-) % 2019 2018 Revenues from sales and services
of 3,400 million Baht in the Consolidated Financial Statements in Q1 2018. Statement of Financial Position Assets As at 31 March 2019, the total assets were 21,507 million Baht; decreased by 105
paid 0 (0) +100% Cash from other financing activities 0 0 - Net Cash flows from (used in) financing activities (75) 316 -124% Exchange differences on translating financial statements 0 0 - Net increase
% Dividend paid 0 (0) +100% Cash from other financing activities 0 0 - Net Cash flows from (used in) financing activities (75) 316 -124% Exchange differences on translating financial statements 0 0 - Net
(“the Company”) has already submitted the consolidated reviewed the 1st quarter financial statements as of May 31, 2019 which were reviewed by Deloitte Touche Tohmatsu Jaiyos Audit Company Limited. The
information contained herein. Further, nothing in this document should be construed as constituting legal, business, tax or financial advice. This material contains “forward-looking” statements that relate to
construed as constituting legal, business, tax or financial advice. This material contains “forward-looking” statements that relate to future events, which are, by their nature, subject to significant risks
September 25, 2017 to operate medical service concerning healthcare and esthetics under trademark “Wuttisak Clinic”. 3. Analysis of Operating Results Profit & Loss Statements (MB) for the Quarter 1 Ending 31
(“the Company”) has already submitted the consolidated reviewed the 1st quarter financial statements as of May 31, 2018 which were reviewed by Deloitte Touche Tohmatsu Jaiyos Audit Company Limited. The